Better Coronavirus Stock: Johnson & Johnson vs. Novavax

Two very different drug companies recently joined the elite group of late-stage coronavirus vaccine companies. Johnson & Johnson (NYSE: JNJ) initiated a Phase 3 global clinical trial of JNJ-78436735 (also known as Ad26.COV2.S) on September 23. Novavax (NASDAQ: NVAX) started Phase 3 testing of its COVID-19 vaccine candidate in the UK the following day.

You should check here to buy the best price guaranteed products.

Last News

Josh Altman Admits He 'Cut' Fredrik Eklund Out of His Life After Finale of MDLLA

Stetson Bennett Celebrates National Championship Win by Working Raising Cane's Drive-Thru

Psychiatrist on Norway mass killer Anders Behring Breivik: 'You cannot trust him'

Former Trump allies subpoenaed by House January 6 committee

Former Trump allies subpoenaed by House January 6 committee

Dakota Johnson on soul-baring, bikini-wearing, and finding her Lost Daughter lodestar